These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 2742849
1. Use of a nitrotryptophan-containing peptide for photoaffinity labeling the pancreatic cholecystokinin receptor. Klueppelberg UG, Gaisano HY, Powers SP, Miller LJ. Biochemistry; 1989 Apr 18; 28(8):3463-8. PubMed ID: 2742849 [Abstract] [Full Text] [Related]
5. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D. Mol Pharmacol; 1994 Apr 15; 45(4):599-607. PubMed ID: 8183238 [Abstract] [Full Text] [Related]
7. Establishment of a new short, protease-resistant, affinity labeling reagent for the cholecystokinin receptor. Pearson RK, Powers SP, Hadac EM, Gaisano H, Miller LJ. Biochem Biophys Res Commun; 1987 Aug 31; 147(1):346-53. PubMed ID: 2443134 [Abstract] [Full Text] [Related]
8. Use of photoaffinity probes containing poly(ethylene glycol) spacers for topographical mapping of the cholecystokinin receptor complex. Powers SP, Foo I, Pinon D, Klueppelberg UG, Hedstrom JF, Miller LJ. Biochemistry; 1991 Jan 22; 30(3):676-82. PubMed ID: 1899032 [Abstract] [Full Text] [Related]
12. The efficiency of covalent labeling of the pancreatic cholecystokinin receptor using a battery of crosslinkable and photolabile probes. Klueppelberg UG, Powers SP, Miller LJ. Receptor; 1991 Jan 22; 1(1-2):1-11. PubMed ID: 2152369 [Abstract] [Full Text] [Related]
13. Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling. Ji Z, Hadac EM, Henne RM, Patel SA, Lybrand TP, Miller LJ. J Biol Chem; 1997 Sep 26; 272(39):24393-401. PubMed ID: 9305898 [Abstract] [Full Text] [Related]
15. The biochemical characterization of the native pancreatic cholecystokinin receptor using affinity labeling approaches. Miller LJ. Yale J Biol Med; 1992 Sep 26; 65(5):441-8; discussion 465-9. PubMed ID: 1340061 [Abstract] [Full Text] [Related]
16. Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. Pearson RK, Miller LJ, Hadac EM, Powers SP. J Biol Chem; 1987 Oct 05; 262(28):13850-6. PubMed ID: 3654639 [Abstract] [Full Text] [Related]
17. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells. Klueppelberg UG, Molero X, Barrett RW, Miller LJ. Mol Pharmacol; 1990 Aug 05; 38(2):159-63. PubMed ID: 2200953 [Abstract] [Full Text] [Related]
18. Structural analysis of a distinct subtype of CCK receptor on human gastric smooth muscle tumors. Pearson RK, Hadac EM, Miller LJ. Am J Physiol; 1989 Jun 05; 256(6 Pt 1):G1005-10. PubMed ID: 2735406 [Abstract] [Full Text] [Related]
19. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely. Hadac EM, Ji Z, Pinon DI, Henne RM, Lybrand TP, Miller LJ. J Med Chem; 1999 Jun 17; 42(12):2105-11. PubMed ID: 10377216 [Abstract] [Full Text] [Related]
20. Purification and characterization of the rat pancreatic cholecystokinin receptor. Duong LT, Hadac EM, Miller LJ, Vlasuk GP. J Biol Chem; 1989 Oct 25; 264(30):17990-6. PubMed ID: 2808360 [Abstract] [Full Text] [Related] Page: [Next] [New Search]